Leptin plays a role in the adverse outcomes of COVID-19: elevated circulating levels of leptin in patients with obesity, associated with the secretion of other cytokines, impair host antiviral defense and reduce the immune response against the virus, leading to clinical aggravation, ARDS and multiple organ failure. Here, LEP is linked to obesity disorder.